Zacks Investment Research on MSN17h
DexCom CGM Sensor Sales to Continue Despite FDA Warning LetterDexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback